◀ Back to TP53
TP53 — XRCC6
Pathways - manually collected, often from reviews:
-
NCI Pathway Database BARD1 signaling events:
BARD1/DNA-PK/p53 complex (TP53-BARD1-PRKDC-XRCC6-XRCC5)
→
p53 (TP53)
(modification, collaborate)
-
NCI Pathway Database BARD1 signaling events:
BARD1/DNA-PK/p53 complex (TP53-BARD1-PRKDC-XRCC6-XRCC5)
→
BARD1/DNA-PK complex (BARD1-PRKDC-XRCC6-XRCC5)
(modification, collaborate)
-
NCI Pathway Database BARD1 signaling events:
p53 (TP53)
→
BARD1/DNA-PK complex (BARD1-PRKDC-XRCC6-XRCC5)
(modification, collaborate)
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Bind Interaction:
XRCC6
—
TP53
Feki et al., Oncogene 2005
-
IRef Bind_translation Interaction:
XRCC6
—
TP53
(coimmunoprecipitation)
Feki et al., Oncogene 2005
-
IRef Biogrid Interaction:
XRCC6
—
TP53
(physical association, affinity chromatography technology)
Feki et al., Oncogene 2005
-
MIPS CORUM P53-BARD1-Ku70 complex:
P53-BARD1-Ku70 complex complex (BARD1-TP53-XRCC6)
Feki et al., Oncogene 2005
-
IRef Corum Interaction:
Complex of TP53-XRCC6-BARD1-XRCC6-TP53-BARD1
(association, coimmunoprecipitation)
Feki et al., Oncogene 2005
-
IRef Hprd Interaction:
XRCC6
—
TP53
(in vivo)
Feki et al., Oncogene 2005
-
IRef Intact Interaction:
XRCC6
—
TP53
(physical association, anti bait coimmunoprecipitation)
Feki et al., Oncogene 2005
-
IRef Intact Interaction:
Complex of 244 proteins
(association, pull down)
Komarova et al., Mol Cell Proteomics 2011
Text-mined interactions from Literome
Abraham et al., Oncogene 1999
:
Recent studies have indicated that
DNA-PK is not
required for the transactivation or apoptosis promoting activities of
p53 protein
Kachnic et al., J Biol Chem 1999
:
Taken together, these data suggest that loss of DNA-PK activity appears to attenuate the kinetics of p53 to activate downstream genes, implying that
DNA-PK plays a role in post-translational modification of
p53 , without affecting the increase in levels of p53 in response to DNA damage
Araki et al., Cancer Res 1999
(Mammary Neoplasms, Experimental) :
Furthermore, we identified a missense point mutation in the p53 DNA binding motif region in SCGR11 cells, which were established from severe combined immunodeficient ( SCID ) mice and used for previous study on the
role of
DNA-PK in
p53 transactivation
Silins et al., Carcinogenesis 2001
(Liver Neoplasms...) :
An inhibitor of
DNA dependent protein kinase (DNA-PK) and ataxia telangiectasia mutated (ATM), wortmannin,
blocked the DEN induced
p53 response in non-EAF hepatocytes
Jack et al., J Biol Chem 2004
:
Using wortmannin, serine 15 mutants of p53, DNA-PK null cells and Chk2 null cells, we demonstrate that
DNA-PK and Chk2
act independently and sequentially on
p53
Soubeyrand et al., Eur J Biochem 2004
:
Our results suggest a
role for
DNA-PK in the modulation of
p53 activity resultant from the convergence of p53 and DNA-PK on structured DNA
Vidal et al., Thromb Haemost 2005
:
Here, we show that ATM and ATR kinases, but not
DNA-PK , which participate in DNA damage activated checkpoints,
regulate the phosphorylation of
p53 at serine 15 in response to MNNG cell treatment
Boehme et al., Proc Natl Acad Sci U S A 2008
:
Correspondingly, down-regulation of
DNA-PK prevented phosphorylation of Akt/PKB and GSK-3 after ionizing radiation and strongly
reduced the accumulation of
p53
Hill et al., DNA repair 2008
:
Chromium induced apoptosis therefore involves
DNA-PK mediated
p53 activation followed by preferential transcription of pro-apoptotic PUMA over anti-apoptotic p21 genes
Sotiropoulou et al., Nat Cell Biol 2010
:
The attenuated
p53 activation is the consequence of a faster DNA repair activity, mediated by a higher non-homologous end joining ( NHEJ ) activity,
induced by the key protein
DNA-PK
Zhao et al., Mol Endocrinol 2011
(Carcinoma, Hepatocellular...) :
Herein, we demonstrate that the orphan nuclear receptor TR3 suppresses DSB repair by blocking Ku80 DNA-end binding activity and promoting
DNA-PK induced
p53 activity in hepatoma cells ... Phosphorylated TR3, in turn, enhances
DNA-PK induced phosphorylation and
p53 transcription activity, thereby enhancing IR-induced apoptosis in hepatoma cells
Williamson et al., EMBO Mol Med 2012
(Disease Models, Animal...) :
In ATM-deficient MCL cells, olaparib induced
DNA-PK dependent phosphorylation and stabilization of
p53 as well as expression of p53-responsive cell cycle checkpoint regulators, and inhibition of DNA-PK reduced the toxicity of olaparib in ATM-deficient MCL cells
Candéias et al., Biochimie 1997
:
Thus, our results show that
DNA-PK is not the main sensor for genotoxic stress and is not
required for
p53 activation ... In fact, they rather suggest that
DNA-PK may
play a role in
p53 down-regulation
Woo et al., Nature 1998
:
We find that p53 is incapable of binding to DNA in the absence of DNA-PK, that
DNA-PK is
necessary but not sufficient for activation of
p53 sequence-specific DNA binding, and that this activation occurs in response to DNA damage